Voyager Therapeutics (VYGR) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to 0.76.
- Voyager Therapeutics' Equity Ratio fell 165.65% to 0.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76, marking a year-over-year decrease of 165.65%. This contributed to the annual value of 0.76 for FY2024, which is 1336.53% up from last year.
- Per Voyager Therapeutics' latest filing, its Equity Ratio stood at 0.76 for Q3 2025, which was down 165.65% from 0.76 recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Equity Ratio ranged from a high of 0.78 in Q3 2024 and a low of 0.32 during Q2 2022
- In the last 5 years, Voyager Therapeutics' Equity Ratio had a median value of 0.63 in 2023 and averaged 0.6.
- In the last 5 years, Voyager Therapeutics' Equity Ratio skyrocketed by 13176.69% in 2021 and then crashed by 4088.8% in 2022.
- Voyager Therapeutics' Equity Ratio (Quarter) stood at 0.49 in 2021, then decreased by 24.47% to 0.37 in 2022, then skyrocketed by 81.64% to 0.67 in 2023, then grew by 13.37% to 0.76 in 2024, then decreased by 0.03% to 0.76 in 2025.
- Its Equity Ratio was 0.76 in Q3 2025, compared to 0.76 in Q2 2025 and 0.77 in Q1 2025.